Lncap-ai prostate cancer cell line establishment by flutamide and androgen-free environment to promote cell adherent

HIGHLIGHTS

• who: Huifeng Wang from the Institute of Life Sciences, Guangxi Medical University, Nanning, Guangxi, China have published the paper: Lncap-AI prostate cancer cell line establishment by Flutamide and androgen-free environment to promote cell adherent, in the Journal: (JOURNAL)
• what: Although the research shows a convenient protocol to prove the Lncap-AI cell line, further studies still need to be used to explore the mechanism of cell adhesion in Fig 2C.

SUMMARY

Prostate cancer (PCa) is the world`s top 10 malignancy disease among men which causes leading to male . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.